Sort by
27 March 2018
UK GOVERNMENT AGREES ELEMENTS OF THE EUROPEAN COMMISSION’S PROPOSALS FOR POST-BREXIT PROTECTION OF EU-WIDE IP RIGHTS IN THE UK
In the latest draft of the Withdrawal Agreement (19 March 2018) the UK Government and European Commission negotiators appear to have agreed text providing for the replacement of EU-wide IP rights having effect in the UK with equivalent UK rights at the end of the transition period post-Brexit (...
24 April 2017
First High Court judgment on FRAND royalties
UK Court takes tough stance on party unwilling to take Worldwide licence on FRAND terms. The UK High Court has handed down its first decision determining FRAND royalties, and has provided clear guidance as to the rights and obligations of parties to licensing negotiations and litigation relating to...
23 March 2017
UPC Preparatory Committee holds final meeting signalling readiness for the UPC's Provisional Application Phase and Germany passes bills necessary to ratify the UPC Agreement
The UPC Preparatory Committee held its final meeting on 15 March at which it agreed a collection of legal, HR and financial documents and confirmed that the Provisional Application Phase could commence once the final Signatory States had acceded to the Protocol on Provisional Application. The...
05 January 2017
Brexit – what IP issues to consider now
We set out our thoughts and predictions upon how protection and enforcement of IP in the UK may be impacted once Brexit arrives. We have also suggested some immediate action points for consideration in the weeks or months to come, prior to Brexit, to ensure that your business is best protected...
06 May 2016
Productivity Commissions Draft Report on IP Implications for the Pharmaceutical Industry
The Productivity Commission ( Commission ) has released its draft report into Intellectual Property Arrangements and made several draft recommendations with the potential to significantly impact IP rights holders in the pharmaceutical industry.
21 January 2016
How high has the bar been raised? The Australian Patent Office issues its first opposition decision on a post ‘Raising the Bar’ patent application
In the first opposition decision of the Australian Patent Office to apply the post-‘Raising the Bar’ disclosure and support requirements, the hearing officer applied principles derived from UK and European case law to find that the opposed application did not meet the new requirements.
08 December 2015
Commonwealth a step closer to compensation for delayed PBS price drops
The Full Federal Court has held that the Therapeutic Goods Act 1989 (Cth) ( TG Act ) does not limit the Commonwealth’s ability to seek compensation for losses arising from the operation of an interlocutory injunction restraining the launch of a generic drug. 1
09 October 2015
High Court of Australia determines isolated BRCA1 gene not patentable in Australia
The High Court of Australia has unanimously overturned previous decisions from lower courts and has held that certain claims to Myriad's patent for isolated BRCA1 nucleic acid molecules are not patentable in Australia.
Loading Results
Loading
Hubs
Recent Articles
22 July 2022
Artificial Intelligence and Renewables: The rise of renewables in Australia
What role will machine learning, a subset of AI, play in Australia's transition to a zero carbon energy future, and what are some of the implications and trade-offs that come with its increased use in our energy infrastructure?
20 July 2022
Trust companies survey 2022: Anti-money laundering regulation
The pace of change in anti-money laundering regulation has been rapid since the 2020 edition of our survey, and shows little sign of slowing down. The EU has introduced a significant AML reform package which is working its way through the legislative process, the UK recently issued responses to...
20 July 2022
‘Safe harbour’ protections may help Australian startups and scaleups ride out the current storm
With a tightening market for capital, the ‘safe harbour’ protections may be critical for Australian startups and scaleups who are unsure if they can raise more capital within their current cash runway or who need to raise through debt securities like convertible notes. Relying on ‘safe harbour’...